Marc-André d'Entremont, Sulaiman Alrashidi, Omar Alansari, Bradley Brochu, Laura Heenan, Elizabeth Skuriat, Jessica Tyrwhitt, Micheal Raco, Micheal Tsang, Nicholas Valettas, James L Velianou, Tej N Sheth, Matthew Sibbald, Shamir R Mehta, Natalia Pinilla-Echeverri, Jon David Schwalm, Madhu K Natarajan, Andrew Kelly, Elie Akl, Sarah Tawadros, Mercedes Camargo, Walaa Faidi, John Bauer, Rachel Moxham, James Nkurunziza, Gustavo Dutra, Jose Winter, Sanjit S Jolly
BACKGROUND: Whether ultrasound (US)-guided femoral access compared to femoral access without US guidance decreases access site complications in patients receiving a vascular closure device (VCD) is unclear. AIMS: We aimed to compare the safety of VCD in patients undergoing US-guided versus non-US-guided femoral arterial access for coronary procedures. METHODS: We performed a prespecified subgroup analysis of the UNIVERSAL trial, a multicentre randomised controlled trial of 1:1 US-guided femoral access versus non-US-guided femoral access, stratified for planned VCD use, for coronary procedures on a background of fluoroscopic landmarking...
February 25, 2023: EuroIntervention